Annual CFF
$25.13 M
+$16.93 M+206.49%
December 31, 2023
Summary
- As of February 22, 2025, ACAD annual cash flow from financing activities is $25.13 million, with the most recent change of +$16.93 million (+206.49%) on December 31, 2023.
- During the last 3 years, ACAD annual CFF has fallen by -$55.87 million (-68.98%).
- ACAD annual CFF is now -95.29% below its all-time high of $533.81 million, reached on December 31, 2016.
Performance
ACAD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$268.00 K
-$3.30 M-92.48%
September 30, 2024
Summary
- As of February 22, 2025, ACAD quarterly cash flow from financing activities is $268.00 thousand, with the most recent change of -$3.30 million (-92.48%) on September 30, 2024.
- Over the past year, ACAD quarterly CFF has dropped by -$12.48 million (-97.90%).
- ACAD quarterly CFF is now -99.92% below its all-time high of $319.97 million, reached on September 30, 2019.
Performance
ACAD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$10.31 M
-$12.48 M-54.77%
September 30, 2024
Summary
- As of February 22, 2025, ACAD TTM cash flow from financing activities is $10.31 million, with the most recent change of -$12.48 million (-54.77%) on September 30, 2024.
- Over the past year, ACAD TTM CFF has dropped by -$11.00 million (-51.62%).
- ACAD TTM CFF is now -98.36% below its all-time high of $629.39 million, reached on September 30, 2019.
Performance
ACAD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ACAD Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +206.5% | -97.9% | -51.6% |
| 3 y3 years | -69.0% | -74.9% | -67.7% |
| 5 y5 years | -91.8% | -99.9% | -97.2% |
ACAD Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +206.5% | -97.9% | at low | -59.0% | +43.2% |
| 5 y | 5-year | -93.2% | +206.5% | -99.4% | at low | -97.5% | +43.2% |
| alltime | all time | -95.3% | +6819.0% | -99.9% | +102.2% | -98.4% | +1460.0% |
ACADIA Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $268.00 K(-92.5%) | $10.31 M(-54.8%) |
| Jun 2024 | - | $3.56 M(+241.8%) | $22.79 M(-7.7%) |
| Mar 2024 | - | $1.04 M(-80.8%) | $24.71 M(-1.7%) |
| Dec 2023 | $25.13 M(+206.5%) | $5.43 M(-57.4%) | $25.13 M(+17.9%) |
| Sep 2023 | - | $12.75 M(+132.8%) | $21.31 M(+140.9%) |
| Jun 2023 | - | $5.48 M(+273.7%) | $8.85 M(+22.9%) |
| Mar 2023 | - | $1.47 M(-9.2%) | $7.20 M(-12.2%) |
| Dec 2022 | $8.20 M(-54.9%) | $1.61 M(+462.4%) | $8.20 M(-25.1%) |
| Sep 2022 | - | $287.00 K(-92.5%) | $10.95 M(-6.6%) |
| Jun 2022 | - | $3.83 M(+55.3%) | $11.73 M(-9.1%) |
| Mar 2022 | - | $2.47 M(-43.5%) | $12.90 M(-29.0%) |
| Dec 2021 | $18.16 M(-77.6%) | $4.37 M(+309.5%) | $18.16 M(-43.1%) |
| Sep 2021 | - | $1.07 M(-78.7%) | $31.92 M(-25.0%) |
| Jun 2021 | - | $5.00 M(-35.2%) | $42.57 M(-49.9%) |
| Mar 2021 | - | $7.73 M(-57.4%) | $84.97 M(+4.9%) |
| Dec 2020 | $81.00 M(-78.2%) | $18.13 M(+54.7%) | $81.00 M(-23.5%) |
| Sep 2020 | - | $11.71 M(-75.3%) | $105.93 M(-74.4%) |
| Jun 2020 | - | $47.40 M(+1162.7%) | $414.18 M(+11.5%) |
| Mar 2020 | - | $3.75 M(-91.3%) | $371.43 M(-0.1%) |
| Dec 2019 | $371.85 M(+21.3%) | $43.06 M(-86.5%) | $371.85 M(-40.9%) |
| Sep 2019 | - | $319.97 M(+6786.9%) | $629.39 M(+103.3%) |
| Jun 2019 | - | $4.65 M(+11.3%) | $309.64 M(+0.5%) |
| Mar 2019 | - | $4.18 M(-98.6%) | $307.94 M(+0.4%) |
| Dec 2018 | $306.65 M(+883.2%) | $300.60 M(>+9900.0%) | $306.65 M(+2730.2%) |
| Sep 2018 | - | $211.00 K(-92.9%) | $10.84 M(-41.5%) |
| Jun 2018 | - | $2.95 M(+2.5%) | $18.52 M(-18.0%) |
| Mar 2018 | - | $2.88 M(-39.9%) | $22.58 M(-27.6%) |
| Dec 2017 | $31.19 M(-94.2%) | $4.79 M(-39.3%) | $31.19 M(+2.6%) |
| Sep 2017 | - | $7.90 M(+12.7%) | $30.38 M(-87.8%) |
| Jun 2017 | - | $7.01 M(-39.0%) | $248.56 M(-5.2%) |
| Mar 2017 | - | $11.49 M(+188.3%) | $262.31 M(-50.9%) |
| Dec 2016 | $533.81 M(+3581.0%) | $3.99 M(-98.2%) | $533.81 M(-1.0%) |
| Sep 2016 | - | $226.08 M(+989.1%) | $539.16 M(+71.6%) |
| Jun 2016 | - | $20.76 M(-92.7%) | $314.21 M(+6.1%) |
| Mar 2016 | - | $282.99 M(+2932.5%) | $296.05 M(+1941.5%) |
| Dec 2015 | $14.50 M(-92.9%) | $9.33 M(+724.4%) | $14.50 M(+81.8%) |
| Sep 2015 | - | $1.13 M(-56.4%) | $7.98 M(-1.8%) |
| Jun 2015 | - | $2.60 M(+80.6%) | $8.13 M(+12.1%) |
| Mar 2015 | - | $1.44 M(-48.7%) | $7.25 M(-96.4%) |
| Dec 2014 | $203.85 M | $2.81 M(+119.0%) | $203.85 M(+1.1%) |
| Sep 2014 | - | $1.28 M(-25.5%) | $201.67 M(+0.2%) |
| Jun 2014 | - | $1.72 M(-99.1%) | $201.37 M(-34.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $198.04 M(>+9900.0%) | $309.52 M(+177.1%) |
| Dec 2013 | $111.68 M(+13.8%) | $629.00 K(-35.4%) | $111.68 M(-44.8%) |
| Sep 2013 | - | $974.00 K(-99.1%) | $202.29 M(-2.8%) |
| Jun 2013 | - | $109.87 M(>+9900.0%) | $208.17 M(+111.6%) |
| Mar 2013 | - | $208.00 K(-99.8%) | $98.36 M(+0.2%) |
| Dec 2012 | $98.17 M(+604.0%) | $91.23 M(+1229.9%) | $98.17 M(+1295.3%) |
| Sep 2012 | - | $6.86 M(>+9900.0%) | $7.04 M(+4138.6%) |
| Jun 2012 | - | $57.00 K(+159.1%) | $166.00 K(+6.4%) |
| Mar 2012 | - | $22.00 K(-77.3%) | $156.00 K(-98.9%) |
| Dec 2011 | $13.94 M(+2866.8%) | $97.00 K(-1070.0%) | $13.94 M(-1.8%) |
| Sep 2011 | - | -$10.00 K(-121.3%) | $14.21 M(-2.3%) |
| Jun 2011 | - | $47.00 K(-99.7%) | $14.53 M(+1.0%) |
| Mar 2011 | - | $13.81 M(+3746.8%) | $14.38 M(+2960.2%) |
| Dec 2010 | $470.00 K(-59.5%) | $359.00 K(+12.9%) | $470.00 K(-60.4%) |
| Sep 2010 | - | $318.00 K(-405.8%) | $1.19 M(-5.7%) |
| Jun 2010 | - | -$104.00 K(+1.0%) | $1.26 M(-1.0%) |
| Mar 2010 | - | -$103.00 K(-109.6%) | $1.27 M(+9.6%) |
| Dec 2009 | $1.16 M(-410.4%) | $1.08 M(+176.2%) | $1.16 M(-4565.4%) |
| Sep 2009 | - | $390.00 K(-528.6%) | -$26.00 K(-95.9%) |
| Jun 2009 | - | -$91.00 K(-57.7%) | -$634.00 K(+48.1%) |
| Mar 2009 | - | -$215.00 K(+95.5%) | -$428.00 K(+14.4%) |
| Dec 2008 | -$374.00 K(-100.4%) | -$110.00 K(-49.5%) | -$374.00 K(+580.0%) |
| Sep 2008 | - | -$218.00 K(-289.6%) | -$55.00 K(-164.0%) |
| Jun 2008 | - | $115.00 K(-171.4%) | $86.00 K(-99.9%) |
| Mar 2008 | - | -$161.00 K(-177.0%) | $96.97 M(-1.3%) |
| Dec 2007 | $98.22 M(+40.3%) | $209.00 K(-371.4%) | $98.22 M(-0.6%) |
| Sep 2007 | - | -$77.00 K(-100.1%) | $98.82 M(-0.5%) |
| Jun 2007 | - | $97.00 M(+8798.9%) | $99.36 M(+59.7%) |
| Mar 2007 | - | $1.09 M(+34.1%) | $62.23 M(-11.1%) |
| Dec 2006 | $70.00 M(+146.7%) | $813.00 K(+77.9%) | $70.00 M(+23.4%) |
| Sep 2006 | - | $457.00 K(-99.2%) | $56.72 M(+0.4%) |
| Jun 2006 | - | $59.87 M(+576.2%) | $56.51 M(+81.7%) |
| Mar 2006 | - | $8.85 M(-171.0%) | $31.10 M(+9.6%) |
| Dec 2005 | $28.37 M(-5.8%) | -$12.47 M(-5086.4%) | $28.37 M(-30.0%) |
| Sep 2005 | - | $250.00 K(-99.3%) | $40.53 M(+1.5%) |
| Jun 2005 | - | $34.46 M(+462.8%) | $39.94 M(+8.0%) |
| Mar 2005 | - | $6.12 M(-2096.4%) | $36.99 M(+22.9%) |
| Dec 2004 | $30.11 M(+14.0%) | -$306.70 K(-10.3%) | $30.11 M(-1.0%) |
| Sep 2004 | - | -$342.10 K(-101.1%) | $30.41 M(-1.1%) |
| Jun 2004 | - | $31.51 M(-4256.8%) | $30.75 M(-4156.8%) |
| Mar 2004 | - | -$758.10 K | -$758.10 K |
| Dec 2003 | $26.40 M(+502.1%) | - | - |
| Dec 2002 | $4.39 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual CFF year-on-year change?
- What is ACADIA Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly CFF year-on-year change?
- What is ACADIA Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM CFF year-on-year change?
What is ACADIA Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ACAD is $25.13 M
What is the all time high annual CFF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual cash flow from financing activities is $533.81 M
What is ACADIA Pharmaceuticals annual CFF year-on-year change?
Over the past year, ACAD annual cash flow from financing activities has changed by +$16.93 M (+206.49%)
What is ACADIA Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of ACAD is $268.00 K
What is the all time high quarterly CFF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly cash flow from financing activities is $319.97 M
What is ACADIA Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, ACAD quarterly cash flow from financing activities has changed by -$12.48 M (-97.90%)
What is ACADIA Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of ACAD is $10.31 M
What is the all time high TTM CFF for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM cash flow from financing activities is $629.39 M
What is ACADIA Pharmaceuticals TTM CFF year-on-year change?
Over the past year, ACAD TTM cash flow from financing activities has changed by -$11.00 M (-51.62%)